Synlogic Inc - ESG Rating & Company Profile powered by AI
This report of Synlogic Inc leverages intelligence from across the internet as well as from public filings by Synlogic Inc. If you work at Synlogic Inc and you wish to licence your ESG rating, please get in touch. Check the end of the webpage for potential risks for Synlogic Inc based on sector, geography and size.
Synlogic Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 2.7, social score of 1.6 and governance score of 6.0.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1186 | Simply Better Brands Corp | 3.5 | Medium |
| 1186 | Yunnan Baiyao Group Co Ltd | 3.5 | Medium |
| 1234 | Synlogic Inc | 3.4 | Medium |
| 1234 | Cassava Sciences Inc | 3.4 | Medium |
| 1234 | Brickell Biotech Inc | 3.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Synlogic Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Synlogic Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Synlogic Inc report the average age of the workforce?
Sign up for free to unlockDoes Synlogic Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Synlogic Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Synlogic Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Synlogic Inc offer flexible work?
Sign up for free to unlockDoes Synlogic Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Synlogic Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Synlogic Inc conduct supply chain audits?
Sign up for free to unlockDoes Synlogic Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Synlogic Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Synlogic Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Synlogic Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Synlogic Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Synlogic Inc disclose water use targets?
Sign up for free to unlockDoes Synlogic Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Synlogic Inc have a product recall in the last two years?
Sign up for free to unlockDoes Synlogic Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Synlogic Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Synlogic Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Synlogic Inc disclose parental leave metrics?
Sign up for free to unlockDoes Synlogic Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Synlogic Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Synlogic Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Synlogic Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Synlogic Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Synlogic Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Synlogic Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Synlogic Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Synlogic Inc disclose its waste policy?
Sign up for free to unlockDoes Synlogic Inc report according to TCFD requirements?
Sign up for free to unlockDoes Synlogic Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Synlogic Inc disclose energy use targets?
Sign up for free to unlockDoes Synlogic Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Synlogic Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Synlogic Inc
These potential risks are based on the size, segment and geographies of the company.
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; SYNB2081 to lower uric acid for the potential treatment of gout; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.